Geert’s Concern about the New Covid Variant (JN.1)

Dr. Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development. Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer. He then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager and subsequently joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. Geert is now primarily serving as a Biotech/Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines. Website: Tammy AI Timestamps 1:32: 🎙️ The video is an interview discussing the COVID pandemic and related issues. 8:49: 🔬 The speaker emphasizes the importance of critical voices, science, and truth in the global health arena. 16:08: ⚠️ The discussion highlights the challenges in controlling the transmission of the virus, despite vaccination efforts. 24:09: 🧬 The video discusses the mRNA vaccine and its potential impact on immune responses. 30:38: ⚛️ mRNA vaccines induce low affinity antibodies that recognize immunodominant epitopes and prioritize subdominant epitopes. 38:07: 🦠 The video discusses how antibodies can stabilize the virus, leading to immune escape and infectious variants. 45:26: 🦠 The video discusses the specific message and potential impact of the gn1 variant, and the challenges it poses to existing vaccines. 52:53: 🦠 The mutations in the virus are no longer limited to conserved domains and are now found in other viral proteins, potentially enhancing infection. 1:00:16: 🔬 The video discusses the impact of antibody concentration on immune system recognition and refocusing. 1:07:45: ⚛️ The video discusses the impact of immune pressure on a new variant and the role of innate immunity in unvaccinated individuals. 1:14:43: 🦠 The video discusses the ongoing COVID-19 crisis and the debate surrounding vaccination and boosters. 1:21:59: ⚠️ The speaker discusses the imminent immune pressure on a small domain and the varying outcomes for vaccinated and unvaccinated individuals. 1:29:31: ⏱️ The speakers discuss the urgency of taking action to suppress viral spread and the potential consequences of doing nothing. Latest news, research and updates about COVID-19 and health. Join on Substack: Join on Patreon: #COVID19 #CovidVaccines FREE and Paid Courses Available! Watch videos at McMillan Research: #covid #medicine #research